(Q36228476)

English

Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma (English)

1 reference

Europe PubMed Central

12 August 2017

author name string

Min Wang

1

1 reference

Europe PubMed Central

12 August 2017

Ping Chen

2

1 reference

Europe PubMed Central

12 August 2017

Yan Jia

3

1 reference

Europe PubMed Central

12 August 2017

Na He

4

1 reference

Europe PubMed Central

12 August 2017

Daqi Li

5

1 reference

Europe PubMed Central

12 August 2017

Chunyan Ji

6

1 reference

Europe PubMed Central

12 August 2017

Daoxin Ma

7

1 reference

Europe PubMed Central

12 August 2017

language of work or name

0 references

publication date

1 July 2015

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

6

1 reference

Europe PubMed Central

12 August 2017

20

1 reference

Europe PubMed Central

12 August 2017

17958-17967

1 reference

Europe PubMed Central

12 August 2017

Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Immunological dysregulation in multiple myeloma microenvironment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

The role of regulatory T cells and TH17 cells in multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Interleukin-17 and type 17 helper T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

International staging system for multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

T cells in myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

1 October 2017

Dysfunctional T regulatory cells in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

29 June 2018

The alteration and clinical significance of Th1/Th2/Th17/Treg cells in patients with multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

22 September 2018

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4627228

22 September 2018

Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26255628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deregulated cytokine network and defective Th1 immune response in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26255628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased numbers of T helper 17 cells and the correlation with clinicopathological characteristics in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26255628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26255628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.18632/ONCOTARGET.4641

0 references

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36228476&oldid=1955147606"